MENU
GLUE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Monte Rosa Therapeutics (GLUE) Ownership - Who owns Monte Rosa Therapeutics?
Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins... Show more
Profile
Industry
N/A
Address
321 Harrison Avenue
Phone
+1 617 949-2643
Employees
133
Web
https://www.monterosatx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
257.11M
P/E Ratio
34.83
Total Cash
326.07M
Projected Growth
N/A
Total Debt
41.86M
Revenue
159.49M
Risk (Beta)
0.99
Dividend Yield
N/A
Total Cash/Share
5.30
Total Debt/Equity
N/A
Revenue/Share
2.00 USD as % of share price
Fundamentals
GLUE
Capitalization
257M
P/E Ratio
34.83
Risk (Beta)
0.99
Dividend Yield
N/A
Total Cash
326M
Total Cash/Share
5.30
Total Debt
41.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.00%
Revenue
159M
ROE
N/A
Book Value
275M
P/B Ratio
0.93
Cash Flow
N/A
Earnings
0.12
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
5.61
Current Revenue Per Employee
633798.50
Dividends Per Share - Security
N/A
EBITDA
6.14M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
1.86
Shares Held By Institutions
528M
Shares Outstanding - Current
61.5M
Total Liabilities
118M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-39.769
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
321 Harrison Avenue
Phone
+1 617 949-2643
Employees
133
Web
https://www.monterosatx.com